Differential effect and interaction of monocytes, hyperimmune sera, and immunoglobulin G on the growth of asexual stage Plasmodium falciparum parasites

American Journal of Tropical Medicine and Hygiene

Volumn 60, Issue 1, 1999, Pages 135-141

  Shi, Ya Ping ^a   Udhayakumar, Venkatchalam ^a   Oloo, Aggrey J ^a,b   Nahlen, Bernard L ^a,b   Lal, Altaf A ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b Vec Biol and Contr Res Center   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

HYPERIMMUNE GLOBULIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G3;

ADULT; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ANTIPROTOZOAL ACTIVITY; ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; KENYA; MALE; MONOCYTE; NONHUMAN; NORMAL HUMAN; PLASMODIUM FALCIPARUM;

PLASMODIUM FALCIPARUM; PROTOZOA;

EID: 0345040646     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.1999.60.135     Document Type: Article

References (30)

1. Cohen S, McGregor IA, Carrington SC, 1961. Gammaglobulin and acquired immunity to malaria. Nature 192: 733-737.
2. Brown J, Greenwood BM, Terry RJ, 1986. Cellular mechanisms involved in recovery from acute malaria in Gambian children. Parasite Immunol 8: 551-564.
3. Trager W, Jensen JB, 1976. Human malaria parasites in continuous culture. Science 193: 673-675.
4. Mitchell GH, Butcher GA, Voller A, Cohen S, 1976. The effect of human immune IgG on the in vitro development of Plasmodium falciparum. Parasitology 72: 149-162.
5. Wilson RJM, Phillips RS, 1976. Method to test inhibitory antibodies in sera to wild populations of Plasmodium falciparum. Nature 263: 132-134.
6. Ahlborg N, Wahlin B, Igbal J, Perlmann P, Berzins K, 1993. Epitopcs specificity and capacity to inhibit parasite growth in vitro of human antibodies to repeat sequences of the Plasmodium falciparum antigen Ag332. Parasite Immunol 15: 391-400
7. Brown GV, Anders RF, Mitchell GF, Heywood PC, 1982. Target antigens of purified human immunoglobulins which inhibit growth of Plasmodium falciparum in vitro. Nature 297: 591-593.
8. Wahlin B, Wahlgren M, Perlmann H, Berzins K, Bjorkman A, Patarroyo ME, Perlmann P, 1984. Human antibodies to a Mr 155,000 Plasmodium falciparum antigen efficiently inhibit merozoite invasion. Proc Natl Acad Sci USA 81: 7912-7916.
9. Cohen S, Butcher GA, 1971. Serum antibody in acquired malarial immunity. Trans R Soc Trop Med Hyg 65: 125-135.
10. Edozien JC, Gilles HM, Udeozo IOK, 1962. Adult and cord-blood gamma-globulin and immunity to malaria in Nigerians. Lancet ii: 951-955.
11. McGregor IA, 1964. The passive transfer of human malaria immunity. Am J Trop Med Hyg 13: 237-239.
12. Sabchareon A, Burnouf T, Ouattara T, Attanath H, Bouharoun-Tayoun H, Chantavanich P, Foucault C, Chongsuphajaisiddhi T, Druilhe P, 1991. Parasitological and clinical responses to immunoglobulin administration in P. falciparum malaria. Am J Trop Med Hyg 45: 297-308.
13. Khusmith S, Druilhe P, 1983. Cooperation between antibodies and monocytes that inhibit in vitro proliferation of Plasmodium falciparum. Infect Immun 41: 219-223.
14. Lunel F, Druilhe P, 1989. Effector cells involved in nonspecific and antibody-dependent mechanism directed against Plasmodium falciparum blood stages in vitro. Infect Immun 57: 2043-2049.
15. Bouharoun-Tayoun H, Attanath P, Sabchareon A, Chongsuphajaisiddhi T, Druilhe P, 1990. Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, hut act in cooperation with monocytes. J Exp Med 172: 1633-1641.
16. Bouharoun-Tayoun H, Oeuvray C, Lunel F, Druilhe P, 1995. Mechanisms underlying the monocyte-mediated antibody-dependent killing of Plasmodium falciparum asexual blood stages. J Exp Med 182: 409-418.
17. Rzepczyk CM, Lopez JA, Anderson KL, Alpers MR 1988. Investigation of the effect of monocytes with Papua New Guinea sera on Plasmodium falciparuin in culture. Int J Parasitol 18: 401-406.
18. Beier JC, Perkins PV, Onyango FK, Gargan TP, Oster CN, Whitmire RE, Koech DK, Roberts CR, 1990. Characterization of malaria transmission by Anopheles (Diptera: Culicidae) in western Kenya in preparation for malaria vaccine trials. J Med Entomol 27: 570-577.
19. Harlow E, Lane D, 1988. Antibodies: A Laboratory Manual Cold Spring Harbor, NY: Cold Spring Harbor Press, 298-302.
20. Heyde HC van der, Merle Elloso M, vandce Waa J, Schell K, Weidanz WP, 1995. Use of hydroethidine and flow cytometry to assess the effects of leukocytes on the malaria parasite Plasmodium falciparum. Clin Diagn Lab Immunol 2: 417-425.
21. Jensen JB, 1978. Concentration from continuous culture of erythrocytes infected with trophozoites and schizonts of Plasmodium falciparum. Am J Trop Med Hyg 27: 1274-1276.
22. Sulzer AJ, Wilson M, Hall EC, 1969. Indirect fluorescent antibody tests for parasitic disease. V. An evaluation of a thick-smear antigen in the IFA test for malaria antibodies. Am J Trop Med Hyg 18: 199-205.
23. Ferrante A, Kumaratilake LM, Rzepczyk CM, Dayer JM, 1990. Killing of Plasmodium falciparum by cytokine activated effector cells (neutrophil and macrophages). Immunol Lett 25: 179-188.
24. Jones KR, Cottrel BJ, Targett GAT, Playfair JHL, 1989. Killing of Plasmodium falciparum by human monocyte-derived macrophages. Parasite Immunol 11: 585-592.
25. Ockenhouse CF, Schulnian S, Shear HL, 1984. Induction of crisis forms in the human malaria parasite Plasmodium falciparum by γ-interferon-activated, monocyte-derived macrophages. J Immunol 133: 1601-1608.
26. Rockett KA, Targett GA, Playfair JHL, 1988. Killing of blood stage Plasmodium falciparum by lipid peroxides from tumor necrosis serum. Inject Immun 56: 3180-3183.
27. Clark MR, Stuart SG, Kimberly RP, Dry PA, Goldstein IM, 1991. A single amino acid distinguishes the higher-responder from the low-responder form of Fc receptor II on human monocytes. Eur J Immunol 21: 1911-1916.
28. Bouharoun-Tayoun H, Druilhe P, 1992. Plasmodium falciparum malaria: evidence for an isotype imbalance which may be responsible for delayed acquisition of protective immunity. Infect Immun 60: 1473-1481.
29. Abbas AK, Lichtman AH, Pober JS, 1991. Cellular and Molecular Immunology. Philadelphia: W. B. Saunders Company, 56-58.
30. Shi YP, Sayed S, Qari SH, Roberts JM, Udhaykumar V, Oloo AJ, Hawley WA, Kaslow DC, Nahlen BL, Lal AA, 1996. Natural immune response to the C-terminal 19-kilodalton domain of Plasmodium falciparum merozoite surface protein I. Infect Immun 64: 2716-2723.